Mengjie Hu


Department of Biochemistry and Molecular Biology

University of Melbourne

Dr Mengjie Hu completed her Bachelor of Science at the University of Melbourne, followed by a Masters degree in Biomedical Science in 2012, where she investigated mitochondrial biochemistry with Associate Professor Marie Bogoyevitch at the Bio21 Institute, leading to a first author publication in Biochemical Journal. Mengjie subsequently worked as a Research Scientist and Project Team Leader in a multinational pharmaceutical company. In 2014, she commenced her PhD at the University of Melbourne with the support of Melbourne International Research and International Fee Remission Scholarships in the labs of Associate Professor Marie Bogoyevitch and Professor David Jans (Monash University). There, she investigated how infection by respiratory syncytial virus (RSV) impacts mitochondrial morphology and function, and conversely how manipulation of mitochondrial function can impact RSV infection. Her work developed a new therapeutic approach to combating RSV infection, culminating in first author publications in Biochemical and Biophysical Research Communications, eLife, Cells, and a comprehensive review in Physiological Reviews, as well as several awards in 3 Minute Thesis Competitions. Mengjie was awarded her PhD in 2019 along with the Sawyer Medal from the Department of Biochemistry and Molecular Biology at the University of Melbourne in recognition of her outstanding research achievements. Since then, Mengjie has worked on a number of projects involving other infectious viruses including Dengue and Zika, and has recently embarked on a new journey in clinical research.

This ASBMB Fellowship was to give Mengjie an opportunity to present her findings at the 16th World Congress on Virology, Emerging Diseases & Vaccines in Italy, and then visit several eminent laboratories at Imperial College in London.